EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
At EAHP, we are committed to transparency in our governance, ethical standards, and funding practices. This section provides open access to our foundational documents, including the EAHP Statutes, Code of Conduct, and Funding Sources. By sharing these resources, we aim to uphold accountability and foster trust with our members, partners, and the public.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
The EAHP EU Monitor is a weekly round up of news relevant to hospital pharmacy in Europe.
You can subscribe to the EAHP EU Monitor here.
The European Association of Hospital Pharmacists has joined over 200 health sector associations and organisations from across Europe in calling for improved transparency and disclosure of clinical trial results.
More information here.
The Internal Market Committee (IMCO) of the European Parliament has announced it has reached a level of agreement with the EU's Irish Presidency of the Council of Ministers on the issue of reforming the existing Directive on the mutual recognition of professional qualifications.
Following the passage of a report by the European Parliament on the subject file at the end of January 2013, a period of ‘trilogue’ discussion between the European Parliament, European Commission and Council of Ministers has been conducted with the aim of reaching compromise and consensus on the key changes.
Speaking at the end of a recent trilogue meeting, Bernadette Vergnaud MEP (France, Parti Socialiste) announced that a provisional deal had been struck and that “We have delivered a text with many concrete improvements for citizens and especially the introduction of a European professional card, which I have advocated since 2007 and will soon become a reality. Tools for facilitating mobility, are also instruments of European citizenship, proving that Europe can work to improve everyday life".
The deal, on a draft directive, would require member states and the Commission to take into account the wish of the professional bodies to opt for EU professional qualifications card for their members. If so, member states would grant the cards, which professionals could use then as a "passport" for mutual recognition purposes.
The deal also should accelerate the recognition process, which in some cases could take no more than four weeks, and would be based on the existing electronic information exchange system between member states' administrations.
The European Parliament had also signalled its support for the recommendation of EAHP, and other organisations representing specialist professions, that new mechanisms for qualification recognition for post-graduate training in the pharmacy, veterinary and nursing professions be created, similar to those already in existing for specialties of dentistry and medicine. EAHP understands this proposal is still under active consideration.
More information here.
On 29 May the European Parliament's Committee on Environment and Public Health (ENVI) voted on its scrutiny report on a proposed new clinical trials regulation, which intends to improve data transparency by requiring that detailed summaries be published in a publicly accessible EU database and by fining those sponsors who do not comply.
The Committee’s report, led by Glenis Willmott (UK, Labour Party) includes amendments to the Commission’s proposed regulation on clinical trials that would require trial sponsors to publish full clinical study reports once a marketing authorization decision has been taken. These amendments also make clear that such publication should take place irrespective of the outcome of the clinical trial, or if the trial was terminated early. Such trial results should be “accompanied by a summary presented in terms that are easily understandable to a layperson.”
However a proposed amendment by the Socialists and Democrats Group (S&D), the Greens/EFA, and European United Left – Nordic Green Left, which would have included in the legal text of the regulation the statement that “Data and information contained in the clinical study report shall not be considered commercially confidential once a marketing authorisation for the medicinal product for which trial was conducted has been granted” was rejected. An aspiration amendment along these lines, to be included in the non-legal part of the Directive, was accepted (amendment 41).
A further amendment was also passed stating that what is considered as commercially confidential has to be in accordance with EMA guidelines and cannot override public health research interests
In response to the vote, the European Federation of Pharmaceutical Industries and Associations released a statement in which they welcomed the Commission's proposal for an effective, safe simplified, and robust clinical trials authorization process, also a part of the new legislation, but expressed concerns over confidentiality of clinical data saying that "several of the amendments supported by the ENVI committee with jeopardize patient privacy, the integrity of regulatory systems, and incentives for investment in biomedical research in Europe."
The ENVI committee final report on the clinical trials regulation will now go on to be voted by the Parliament as a whole (in plenary session). After that negotiations with national governments will begin.
EJHP: June 2013, Volume 20, Issue 3 now online!The June 2013 (Volume 20, Issue 3) edition of the European Journal of Hospital Pharmacy is now available online!
This issue includes: editorial articles on assessing the shelf life of injectable biologicals in ready-to-administer containers, and the management of fatigue in patients; and original articles on effective clinical decision support, the application of lean methods to compounding services in hospital pharmacy, and a comparison of antimicrobial prescribing between two specialist paediatric centres in the UK and Latvia.
More information here.
